Instil Bio, Inc.

NASDAQ:TIL

19.06 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 00007.670000000000000.0520.0420.044
Cost of Revenue 0010.9931.0360.9530.8352.0470.8072.4050.9791.7960.8930.7640.6560.4390000
Gross Profit 00-1-0.9936.634-0.953-0.835-2.047-0.807-2.405-0.979-1.796-0.893-0.764-0.656-0.43900.0520.0420.044
Gross Profit Ratio 00000.865000000000000111
Reseach & Development Expenses 1.099102.9217.2561.9838.4928.45920.6720.72239.6641.539.17442.57729.06421.18614.42410.2474.9082.2372.007
General & Administrative Expenses 10.37310.70710.70612.42410.87211.94111.51813.22212.9116.98917.22415.11211.17513.9614.1958.9797.232.8552.3981.9
Selling & Marketing Expenses 000-0.993-1.036000000000000000
SG&A 10.37310.70710.70611.4319.83611.94111.51813.22212.9116.98917.22415.11211.17513.9614.1958.9797.232.8552.3981.9
Other Expenses 0.3472.924-1-0.428-0.1246.2830.628-0.0571.299-0.415-1.032-0.319-0.5380000000
Operating Expenses 11.81923.63112.62718.68711.81966.71619.97733.89233.63256.64958.72454.28653.75243.02435.38123.40317.4777.7634.6353.907
Operating Income -11.819-23.631-13.627-19.68-12.855-66.716-20.987-58.446-56.799-56.649-58.724-54.286-53.752-43.024-35.381-23.403-17.477-7.711-4.593-3.863
Operating Income Ratio 0000-1.676000000000000-148.288-109.357-87.795
Total Other Income Expenses Net -0.0760.61-1.29-4.622-0.07-0.7162.3251.3782.350.054-0.877-0.319-0.538-0.639-0.0890.0710.4430.449-4.609-0.226
Income Before Tax -11.895-23.021-14.917-24.302-12.925-67.432-18.662-57.068-54.449-56.595-59.601-54.605-54.29-43.663-35.47-23.332-17.034-7.262-9.202-4.089
Income Before Tax Ratio 0000-1.685000000000000-139.654-219.095-92.932
Income Tax Expense 0000.951.468-0.9530.227-0.742-0.605-0.371-0.609-0.4881.06-0.658-0.159-0.2040.151-0.4494.6090.226
Net Income -11.895-23.021-14.917-24.302-12.925-67.432-18.662-56.326-53.844-56.224-58.992-54.117-55.35-43.005-35.311-23.128-17.185-7.262-9.202-4.089
Net Income Ratio 0000-1.685000000000000-139.654-219.095-92.932
EPS -1.82-3.54-2.29-3.74-1.99-10.37-2.87-8.66-8.29-0.43-0.46-0.42-0.43-0.33-0.27-0.66-0.49-0.12-0.15-0.066
EPS Diluted -1.82-3.54-2.29-3.74-1.99-10.37-2.87-8.66-8.29-0.43-0.46-0.42-0.43-0.33-0.27-0.66-0.49-0.12-0.15-0.066
EBITDA -9.145-20.114-11.918-21.577-9.909-64.476-17.237-54.385-52.897-53.383-58.724-52.809-53.397-42.899-34.814-22.893-17.329-7.644-4.559-3.856
EBITDA Ratio 0000-1.541000000000000-147-108.548-87.636